Market Tracker

02/21 4:27pm ET

Sarepta Therapeutics Inc (NASDAQ:SRPT)

28.68
Delayed Data
As of 4:00pm ET
 +0.40 / +1.41%
Today’s Change
8.00
Today|||52-Week Range
63.73
+4.56%
Year-to-Date
Sarepta Leads Biotech Movers on Voucher Deal News
10:18am / TheStreet.com - Paid Partner Content
The Fed's Dilemma Is Quite Obvious
Feb 14 / TheStreet.com - Paid Partner Content
Biotech Stock Mailbag: Bulls Love a Distracted Trump, Protalix, Acadia, Sarepta
Feb 17 / TheStreet.com - Paid Partner Content
Defending Sarepta Against Blowback from the Marathon Pharma Steroid Price Gouging Sca...
Feb 14 / TheStreet.com - Paid Partner Content
3 Biotech Stocks to Buy in February
Feb 16 / MotleyFool.com - Paid Partner Content
Pharma stocks rally on Trump pledge to speed drug approvals
Feb 02 / FT.com - Paid Partner Content

Today’s Trading

Previous close28.28
Today’s open28.88
Day’s range28.08 - 29.00
Volume2,124,769
Average volume (3 months)2,516,469
Market cap$1.5B
Dividend yield--
Data as of 4:00pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)-53.39%
Earnings growth (this year)+3.83%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)-87.16%
P/E ratioNM
Price/Sales1,302.11
Price/Book6.78

Competitors

 Today’s
change
Today’s
% change
AERIAerie Pharmaceutical...-0.90-2.01%
PBYIPuma Biotechnology I...-1.90-4.72%
HCMHutchison China Medi...-0.06-0.45%
PCRXPacira Pharmaceutica...+0.45+1.03%
Data as of 4:00pm ET, 02/21/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$1.23
Annual revenue (last year)$1.3M
Annual profit (last year)-$220.0M
Net profit margin-17,560.26%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive &
Medical Officer
Edward M. Kaye
Chief Financial Officer &
Senior Vice President
Sandesh Mahatme
Corporate headquarters
Cambridge, Massachusetts

Forecasts